MED

Medifast, Inc.

MED · CIK 910329 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$0.4B
20182025
Net Income−$0.0B
20182025
Operating CF$0.0B
20182025
Free Cash Flow$0.0B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.4B$0.6B$1.1B——$0.3B$0.2B$0.1B
Cost of Revenue$0.1B$0.2B$0.3B$0.5B$0.4B$0.2B$0.2B$0.1B
Gross Profit$0.3B$0.4B$0.8B$1.1B$1.1B$0.2B$0.1B$0.1B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.3B$0.4B$0.6B$1.0B$0.9B$0.6B$0.4B$0.3B
Operating Income$-0.0B$0.0B$0.1B$0.2B$0.2B$0.1B$0.1B$0.1B
Net Income$-0.0B$0.0B$0.1B$0.1B$0.2B$0.0B$0.0B$0.0B
EPS (Basic)$-1.70$0.19$9.13$12.82$14.01$2.38$1.71$1.32
EPS (Diluted)$-1.70$0.19$9.10$12.73$13.89$2.36$1.66$1.30

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.2B$0.3B$0.3B$0.3B$0.4B$0.3B$0.2B$0.2B
Current Assets$0.2B$0.2B$0.2B$0.2B$0.3B$0.2B$0.2B$0.1B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B
Total Liabilities$0.0B$0.1B$0.1B$0.2B$0.2B$0.1B$0.1B$0.1B
Current Liabilities$0.0B$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B
Stockholders' Equity$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.0B$0.0B$0.1B$0.2B$0.1B$0.1B$0.1B$0.1B
Investing Cash Flow$-0.0B$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$-0.1B$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B
← Companies